Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing prevalence of influenza and viral infections
3.2.1.2 Ease of administration
3.2.1.3 Growing investment in research and development of microneedle technology
3.2.2 Industry pitfalls & challenges
3.2.2.1 Complications and risks associated with microneedles
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Pipeline analysis
3.6 Porter’s analysis
3.7 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company matrix analysis
4.3 Competitive analysis of major market players
4.4 Competitive positioning matrix
4.5 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Product Type, 2021 – 2032 ($ Mn)
5.1 Key trends
5.2 Solid microneedle
5.3 Hollow microneedle
5.4 Coated microneedle
5.5 Dissolving microneedle
Chapter 6 Market Estimates and Forecast, By Vaccine Type, 2021 – 2032 ($ Mn)
6.1 Key trends
6.2 Trivalent flu vaccine
6.3 Quadrivalent flu vaccine
Chapter 7 Market Estimates and Forecast, By Flu Type, 2021 – 2032 ($ Mn)
7.1 Key trends
7.2 Influenza A
7.2.1 H1N1
7.2.2 H3N1
7.3 Influenza B
Chapter 8 Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)
8.1 Key trends
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 France
8.3.4 Spain
8.3.5 Italy
8.3.6 Netherlands
8.3.7 Rest of Europe
8.4 Asia Pacific
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Australia
8.4.5 South Korea
8.4.6 Rest of Asia Pacific
8.5 Latin America
8.5.1 Brazil
8.5.2 Mexico
8.5.3 Rest of Latin America
8.6 Middle East and Africa
8.6.1 South Africa
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Rest of Middle East and Africa
Chapter 9 Company Profiles
9.1 3M
9.2 Becton, Dickinson and Company
9.3 Corium International, Inc.
9.4 CosMED Pharmaceuticals Co., Ltd
9.5 FluGen, Inc
9.6 Sanofi
